Treatment of hepatitis C in hemodialysis patients using pegylated interferon α-2a in Turkey

Journal of Gastroenterology

Volumn 44, Issue 4, 2009, Pages 353-358

  Kose, Sukran ^a   Gurkan, Alp ^a   Akman, Fatih ^a   Kelesoglu, Mehmet ^b   Uner, Ufuk ^c  

^a Izmir Tepecik Training and Research Hospital   (Turkey)

^b Ugur Dialysis Center   (Turkey)

^c Gunes Dialysis Center   (Turkey)

Author keywords

Hemodialysis patients; Hepatitis C infection; Pegylated interferon 2a

Indexed keywords

HEPATITIS C ANTIBODY; PEGINTERFERON ALPHA2A; VIRUS RNA;

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ADULT; AGED; ANEMIA; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROGNOSIS; QUALITY OF LIFE; RENAL DIALYSIS; RNA, VIRAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 65049089438     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0016-z     Document Type: Article

References (20)

1. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3:41-5.
2. Muir AJ, Bornstein JD, Killenberg PG. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med. 2004;350:2265-71.
3. Poordad FFF, Fabrizi Martin P. Hepatitis C infection associated with renal disease and chronic renal failure. Semin Liver Dis. 2004;24(Suppl 2):69-77.
4. Bozdayi G, Rota S, Verdi H, Derici U, Sindel S. Investigation of the presence of hepatitis C virus infection in haemodialysis patients and determination of HCV genotypes. Bull Microbiol. 2002;36:247-52.
5. Koksal I, Biberoglu K, Biberoglu S, Koc F, Ayma Y, Koksal H. Hepatitis C virus antibodies among risk groups in Turkey. Infection. 1991;19:228-9.
6. Fabrizi F, Poordad F, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002;36:3-10.
7. Gane E. Renal transplantation in chronic hepatitis. J Gastroenterol Hepatol. 2004;19:99-102.
8. Meyers CM, Seeff LB, Stehman-Breen CO, et al. Hepatitis C and renal disease: An update. Am J Kidney Dis. 2003;42:631-57.
9. Kokoglu OF, Uçmak H, Hosoglu S, Cetinkaya A, Kantarceken B, Buyukbese MA, et al. Efficacy and tolerability of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C. J Gastroenterol Hepatol. 2006;21:575-80.
10. Bruchfeld A, Lindahl K, Reichard O, et al. Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients. J Viral Hepatol. 2006;13:316-21.
11. Sikole A, Dzekova P, Selja N, Gaseva M, Nikolov IG, Zabzun M, et al. Treatment of hepatitis C in hemodialysis patients with pegylated interferon α-2a as Monotherapy. Renal Fail. 2007;29:961-6.
12. Casanovas-Taltavull T, Baliellas C, Llobet M, Cruzado JM, Castellote J, Casanova A, et al. Preliminary results of treatment with pegylated interferon α-2a for chronic hepatitis C virus in kidney transplant candidates on hemodialysis. Transpl Proc. 2007;39:2125-7.
13. Teta D, Luscher BL, Gonvers JJ, et al. Pegylated interferon for the treatment of hepatitis C virus in hemodialysis patients. Nephrol Dial Transplant. 2005;20:991-3.
14. Russo MW, Ghalib L, Sigal S, Joshi V. Randomized trial of pegylated interferon α-2b monotherapy in haemodialysis patients with chronic hepatitis C. Nephrol Dial Transpl. 2006;21:437-43.
15. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. AASLD practice guideline. Hepatology. 2004;39:1147-71.
16. Sporea I, Popescu A, Sirli R, et al. Pegylated-interferon α-2a treatment for chronic hepatitis C in patients on chronic hemodialysis. World J Gastroenterol. 2006;12:4191-4.
17. La-Roche H. Pegasys treatment algorithm for healthcare professionals. 2006. Available at: http://www.pegasys.com/treatment/default.aspx.
18. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV) infected patients transplanted with an HCV-infected kidney. Transplantation. 1995;60:642-7.
19. Fabrizi F, Dulai G, Dixit V, et al. Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther. 2003;18:1071-81.
20. http://tsn.org.tr/documents/registry/TND%20Registry%20kure%20son.pdf, 30 June 2008.